Loss of Androgen-Regulated MicroRNA 1 Activates SRC and Promotes Prostate Cancer Bone Metastasis
Open Access
- 1 June 2015
- journal article
- research article
- Published by Taylor & Francis in Molecular and Cellular Biology
- Vol. 35 (11) , 1940-1951
Abstract
Bone metastasis is the hallmark of progressive and castration resistant prostate cancers. miR-1 levels are decreased in clinical samples of primary prostate cancer and further reduced in metastases. SRC has been implicated as a critical factor in bone metastasis, and here we show that SRC is a direct target of miR-1. In prostate cancer patient samples, miR-1 levels are inversely correlated with SRC expression and a SRC dependent gene signature. Ectopic miR-1 expression inhibited ERK signaling and bone metastasis in a xenograft model. In contrast, SRC overexpression was sufficient to reconstitute bone metastasis and ERK signaling in cells expressing high levels of miR-1. AR activity, defined by an AR output signature, is low in a portion of castration resistant prostate cancer. We show that AR binds to the miR-1-2 regulatory region, and regulates miR-1 transcription. Patients with low miR-1 levels displayed correlated low canonical AR gene signatures. Our data support the existence of an AR, miR-1, SRC regulatory network. We propose that loss of miR-1 is one mechanistic link between low canonical AR output and SRC promoted metastatic phenotypes.Keywords
This publication has 46 references indexed in Scilit:
- New and Emerging Therapies for Bone Metastases in Genitourinary CancersEuropean Urology, 2013
- Functional Role of MicroRNAs in Prostate Cancer and Therapeutic OpportunitiesCritical Reviews™ in Oncogenesis, 2013
- MicroRNA-1 is a candidate tumor suppressor and prognostic marker in human prostate cancerNucleic Acids Research, 2011
- Cell Autonomous Role of PTEN in Regulating Castration-Resistant Prostate Cancer GrowthCancer Cell, 2011
- Androgen Receptor Regulates a Distinct Transcription Program in Androgen-Independent Prostate CancerCell, 2009
- Src Family Kinase Activity Is Up-Regulated in Hormone-Refractory Prostate CancerClinical Cancer Research, 2009
- Lentivirus‐mediated bifunctional cell labeling for in vivo melanoma studyPigment Cell & Melanoma Research, 2009
- Gene expression signature-based chemical genomic prediction identifies a novel class of HSP90 pathway modulatorsCancer Cell, 2006
- Molecular determinants of resistance to antiandrogen therapyNature Medicine, 2003
- Phenotypic heterogeneity of end-stage prostate carcinoma metastatic to boneHuman Pathology, 2003